Art Of Designing A Novel Drug Formulation With Patient In Mind

Abstract

Patients, ultimately consumer in traditional means, and health care systems will not accept new drug that fail to conform to consumer preferences or fail to deliver expected results in real world use because it will lead to increase the lack of patient adherence and that will ultimately cost to Pharmaceutical Industries. If research driven pharmaceutical industries still remain unengaged with patients during the Novel Drug Formulation development, then they are at risk of misinterpreting the need of patient that ultimately likely to have significant financial ramifications. Therefore, developing a therapy that ensure improvement in the lives of patients and their adherence to the therapy should be first rooted through a firm understanding of all aspects of the challenges faced by patients in their daily lives, during treatment, their needs and trade-offs they are willing to make to gain relief prior to conceptualisation of product design, research prioritization, product development, trial design, regulatory approval, access, reimbursement, and treatment decisions.